Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity RatioInvested CapitalReturn on AssetsReturn on Capital Employed

Cardiol Therapeutics (CRDL) Return on Assets (2021 - 2026)

Cardiol Therapeutics filings provide 2 years of Return on Assets readings, the most recent being 0.01% for Q4 2022.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.01% in Q4 2022 year-over-year; TTM through Dec 2022 was 0.01%, a 0.0% change, with the full-year FY2022 number at 0.01%, changed 0.0% from a year prior.
  • Return on Assets hit 0.01% in Q4 2022 for Cardiol Therapeutics, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.01% in Q3 2021.